A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer
Status:
Completed
Trial end date:
2018-03-06
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy in Korea or Taiwan of oral
abiraterone acetate and oral prednisolone in men with metastatic-castration resistant
prostate cancer (mCRPC) and with disease progression following treatment with a
docetaxel-containing chemotherapy.